Skip to main content
. 2022 Nov 22;29(12):9046–9065. doi: 10.3390/curroncol29120709

Figure 5.

Figure 5

Forest plot of risk ratios for all grade adverse events in patients with ES-SCLC and treated with chemo-ICI versus standard chemotherapy. PD-1/PD-L1, programmed death (ligand)-1; CTLA-4, cytotoxic T-lymphocyte-associated protein 4; HR, hazard ratio; CI, confidence interval; M-H, Mantel–Haenszel.